Tag - pharmaceuticals

 
Menu
Search
 
July 04, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
WORLD
May 19, 2020
Trump says he’s taking anti-malaria drug that led to FDA warning
Trump is a self-admitted germophobe, telling reporters he was wary of shaking hands even before the coronavirus pandemic.
Japan Times
WORLD / Science & Health
May 14, 2020
France says ‘unacceptable’ for U.S. to get Sanofi vaccine first
Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be "unacceptable,” a French government minister said.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan Times
JAPAN / FOCUS
May 12, 2020
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter.
Japan Times
WORLD / Science & Health
Apr 26, 2020
Countries and companies risk billions in race for coronavirus vaccine
Governments, charities and Big Pharma firms are making huge bets with extraordinarily low odds of success.
Japan Times
WORLD
Apr 23, 2020
Official says he was ousted for urging caution on Trump-touted virus drug
The ousted director of a key U.S. agency charged with developing drugs to fight the COVID-19 pandemic said Wednesday he was dismissed because he called for careful vetting of a treatment frequently touted by President Donald Trump.
Japan Times
WORLD / Science & Health
Apr 22, 2020
Hydroxychloroquine, championed by Trump for virus, may raise death risk
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
BUSINESS / Companies
Apr 15, 2020
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19.
Japan Times
WORLD / Science & Health
Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said.
Japan Times
ASIA PACIFIC / Science & Health
Apr 7, 2020
After Trump threat, India lifts export ban on COVID-19 treatment drug
India has partially lifted a ban on the exports of a malaria drug after U.S. President Donald Trump sought supplies for the United States, according to government officials with knowledge of the matter.
Japan Times
WORLD / Science & Health / FOCUS
Apr 6, 2020
Fast-moving virus pits treating patients against finding a cure
Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.
Japan Times
BUSINESS / Companies
Mar 31, 2020
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available.
JAPAN / Science & Health
Mar 24, 2020
Japan to join trial to test Ebola drug on COVID-19 patients
The National Center for Global Health and Medicine (NCGM) said Monday that it will join an international clinical trial on the use of remdesivir, which is being developed as a remedy for Ebola, to treat people infected with the new coronavirus.
Japan Times
JAPAN / Science & Health
Mar 19, 2020
Japanese researchers to test blood thinner for coronavirus treatment
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday.
Japan Times
WORLD / Science & Health
Mar 19, 2020
HIV drug combo fails as treatment for severe COVID-19 in China study
A pill containing two HIV drugs that was touted as a potential treatment for the novel coronavirus was not effective, according to a study released late on Wednesday in the New England Journal of Medicine.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
BUSINESS
Feb 24, 2020
Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports
British Prime Minister Boris Johnson is prepared to begin trade talks with the United States within the coming two weeks, the Telegraph reported on Sunday.
Magnitude 5.5 earthquake jars Tokara Islands amid flurry of seismic activity
A strong quake struck off the Tokara Islands on Thursday afternoon, with the island chain having recorded around 1,000 earthquakes since a burst of seismic activity first began on June 21.
Onosato's yokozuna promotion causes rare quirk in new sumo rankings
Newly promoted yokozuna Onosato holds a copy of the latest banzuke ranking in Anjo, Aichi Prefecture, on Monday.
A prophesied disaster (likely) won’t strike Japan this weekend
A viral manga prediction of a July 5 disaster has gripped Japan with anxiety and triggered an economic impact, but experts warn that while such dates are unreliable, the threat of a massive earthquake remains real. 
Over 900 earthquakes strike Tokara islands in space of two weeks
A screenshot shows many quakes occurring in the Tokara islands over the past 30 days, in this image taken from the U.S. Geological Survey website.
Ghibli’s Isao Takahata exhibit shows how beloved anime is made
“The man who planted Japanese animation” exhibition includes a variety of sketches, drawings and animation cels from Isao Takahata films such as color design for characters by Michiyo Yasuda from "Grave of the Fireflies."
Ghibli’s Isao Takahata exhibit shows how beloved anime is made
“The man who planted Japanese animation” exhibition includes a variety of sketches, drawings and animation cels from Isao Takahata films such as color design for characters by Michiyo Yasuda from "Grave of the Fireflies."
Flag football facing challenges and opportunities ahead
Japan’s women’s flag football team at the 2025 International Bowl in Los Angeles in June. The sport is enjoying continued growth in the country.
From Hokusai’s Great Wave, shinkansen to One Piece: a cultural treasure box for Lego Japan
Michael Ebbesen, general manager of Lego Japan, says Lego bricks based on Japanese culture have a rich global appeal and are sellable around the world.
With farmed fish, RelationFish swims against the tide in fine dining
Chef Hideaki Matsuo (middle) and the staff of Oseto Suisan Fisheries prepare to check on their sustainably farmed fish.
As Southeast Asia heats up, a Japanese cooling giant sees a major opportunity
An employee of Daikin Cambodia explains the use of different tools during an air conditioner installation training session in Phnom Penh. Daikin is one of Japan’s oldest air conditioning companies, but as Japan’s population falls, the firm is keying in on overseas growth.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji
By Alex K.T. Martin

SUSTAINABLE JAPAN

Ishii Iron Works remakes self for workers, new energy
Ishii Iron Works remakes self for workers, new energy

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER